Hypothyroidism and nephrotic syndrome: why, when and how to treat [PDF]
, 2017 Hypothyroidism, characterised by low/normal free thyroxine (FT4) and free tri-iodothyronine (FT3) with elevated thyroid-stimulating hormone (TSH), is a well-known complication of nephrotic syndrome (NS).
Barbano, Biagio +7 more
core +1 more source
Source, triggers and clinical implications of hyperlactemia in patients undergoing mitral valve surgery using Custodiol cardioplegia [PDF]
, 2013 Postoperative blood hyperlactaemia is an indicator of organ anaerobic metabolism and is associated with morbidity after cardiac surgery. This prospective study aims to explore the source, triggers and clinical implications for hyperlactaemia in patients ...
Angelini, Gianni D +7 more
core +2 more sources
What every ICU clinician needs to know about the cardiovascular effects caused by abdominal hypertension [PDF]
, 2015 The effects of increased intra-abdominal pressure (IAP) on cardiovascular function are well recognized and include a combined negative effect on preload, afterload and contractility.
De Keulenaer, Bart L +2 more
core +1 more source
Association between serum Mg2+ concentrations and cardiovascular organ damage in a cohort of adult subjects [PDF]
, 2020 Magnesium (Mg2+) levels are associated with insulin resistance, hypertension, atherosclerosis, and type 2 diabetes (T2DM). We evaluated the clinical utility of physiological Mg2+ in assessing subclinical cardiovascular organ damage including increased ...
Andreozzi, F. +12 more
core +1 more source
Risk factor analysis for fast track protocol failure [PDF]
, 2013 Background: The introduction of fast-track treatment procedures following cardiac surgery has significantly shortened hospitalisation times in intensive care units (ICU).
Bingold, Tobias Michael +5 more
core +1 more source
Liraglutide and renal outcomes in type 2 diabetes [PDF]
, 2017 In a randomized, controlled trial that compared liraglutide, a glucagon-like peptide 1 analogue, with placebo in patients with type 2 diabetes and high cardiovascular risk who were receiving usual care, we found that liraglutide resulted in lower risks ...
Brown-Frandsen, Kirstine +9 more
core +2 more sources
Cardio-renal-anemia syndrome: A report of three cases
Saudi Journal of Kidney Diseases and Transplantation, 2012 Patients with chronic kidney diseases (CKDs) and cardiovascular diseases (CVDs) present with various degree of anemia. Anemia has been associated with poor outcome in patients with CKD and CVD.
U H Okafor, E I Unuigbe
doaj +1 more source
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes [PDF]
, 2016 Background The cardiovascular effect of liraglutide, a glucagon-like peptide 1 analogue, when added to standard care in patients with type 2 diabetes, remains unknown. Methods In this double-blind trial, we randomly assigned patients with type 2 diabetes
Bergenstal, RM +15 more
core +1 more source
The cardio-renal anemia syndrome
Medicinski pregled, 2007 Introduction. The problem of anemia in congestive heart failure and chronic kidney disease was thought to be insignificant for a long period of time. Recent investigations pointed out that the problem of anemia should be defined in the context of the cardio-renal anemia syndrome. A positive feedback mechanism indicates that cardio-renal anemia syndrome
Sinisa, Dimković, Nada, Dimkovic
openaire +3 more sources
Síndrome cardio-renal: os desafios no tratamento da insuficiência cardíaca.
Acta Médica Portuguesa, 2011 Heart failure is a chronic and progressive disease that is estimated to affect approximately 20 million people worldwide and is one of the major public health problems.
Hélia Martins +5 more
doaj +1 more source